trigger factors in ANCA associated vasculitis
Last reviewed 09/2022
- the predominance of respiratory involvement, especially in GPA (Wegener's),
led to investigation of the role of inhaled agents in the development of GPA
- they observed no increase in inhaled particulates and fumes in GPA in general,
but a significant increase in those with respiratory disease
- a number of other possible trigger factors have also been reported, including
silica, solvents, allergy and vaccination. A number of drugs have been implicated
in the development of ANCA associated vasculitis (AAV)
- patients with high-titre MPO antibodies are more likely to have taken hydralazine,
propylthiouracil or allopurinol
- leucotriene antagonists have been associated with development of EGPA (Churg Strauss), probably by unmasking pre-existing disease
Reference:
- 1) ARC Autumn 2012. Topical Reviews - ANCA-associated vasculitis; 1:1-12.